During the first phase of our investigation, a functional genomic screen aiming to locate regulators of anchorage-independent survival helped us zero in on PTK6 as a crucial mediator of anoikis resistance in breast cancer cells [11, 12]. The gene discussed is PTK6; the disease is breast carcinoma.